-->

Tag: Durvalumab FDA approval

Home / Durvalumab FDA approval

Categories

Durvalumab is approved by the USFDA for muscle invasive bladder cancer

On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) to be used with gemcitabine and cisplatin as a first treatment, followed by durvalumab alone as a follow-...
durvalumab-fda-approval

Neoadjuvant/adjuvant durvalumab is approved by the USFDA for resectable non-small cell lung cancer

August 2024: The Food and Drug Administration has granted approval for the use of durvalumab (Imfinzi, AstraZeneca) in combination with platinum-containing chemotherapy as a neoadjuvant treatment, fol...
durvalumab-fda-approval

Scan the code